Back
ESC2025 Premium Access

GLP-1 receptor agonists for obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

Session: Heart failure therapies: current drug strategies
Topic: Pharmacotherapy
Speaker: Mr C. Rodrigues Rosa (Belo Horizonte, BR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Caio Rodrigues Rosa

Belo Horizonte (Brazil)
0 follower

6 more presentations in this session

Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure

Speaker: Doctor L. Xie (Nanjing, CN)

Access
Abstract
Slides
Like
Thumbnail

Levosimendan in advanced heart failure: a step forward in functional recovery and hospitalization reduction

Speaker: Doctor F. Gerardo (Amadora, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Early exercise-based rehabilitation for patients with acute decompensated heart failure: an updated systematic review and meta-analysis

Speaker: Mr D. Abraham (Manaus, BR)

Access
Abstract
Slides
Video
Like
Thumbnail

SGLT2 inhibitor therapy in patients with acute Takotsubo syndrome

Speaker: Doctor L. Arcari (Rome, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Demographic, clinical and treatment patterns of patients with heart failure with reduced ejection fraction (HFrEF) in the Australian primary care setting

Speaker: Associate Professor A. Nelson (Melbourne, AU)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Heart failure therapies: current drug strategies

Speakers: Mr C. Rodrigues Rosa, Doctor L. Xie, Doctor F. Gerardo, Mr D. Abraham, Doctor L. Arcari...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources